IL320213A - ליפידים ניתנים ליוניזציה - Google Patents
ליפידים ניתנים ליוניזציהInfo
- Publication number
- IL320213A IL320213A IL320213A IL32021325A IL320213A IL 320213 A IL320213 A IL 320213A IL 320213 A IL320213 A IL 320213A IL 32021325 A IL32021325 A IL 32021325A IL 320213 A IL320213 A IL 320213A
- Authority
- IL
- Israel
- Prior art keywords
- ionizable lipids
- ionizable
- lipids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22202996 | 2022-10-21 | ||
| PCT/EP2023/079320 WO2024084056A1 (en) | 2022-10-21 | 2023-10-20 | Ionizable lipids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320213A true IL320213A (he) | 2025-06-01 |
Family
ID=83902867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320213A IL320213A (he) | 2022-10-21 | 2023-10-20 | ליפידים ניתנים ליוניזציה |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4605375A1 (he) |
| JP (1) | JP2026512620A (he) |
| KR (1) | KR20250091282A (he) |
| CN (1) | CN120303251A (he) |
| AU (1) | AU2023362573A1 (he) |
| IL (1) | IL320213A (he) |
| WO (1) | WO2024084056A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202541786A (zh) | 2023-12-22 | 2025-11-01 | 比利時商eTheRNA免疫治療公司 | 脂質奈米顆粒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2341311A1 (fr) * | 1976-02-20 | 1977-09-16 | Parcor | Derives de la pyridoxine |
| JP2717481B2 (ja) * | 1992-08-25 | 1998-02-18 | 富士写真フイルム株式会社 | ハロゲン化銀カラー写真感光材料 |
| ATE481385T1 (de) * | 2000-05-31 | 2010-10-15 | Santen Pharmaceutical Co Ltd | (pyridinyl)alkyl-amide oder -harnstoffe als tnf- alpha bildung inhibitoren |
| IL157397A (en) * | 2003-08-14 | 2013-03-24 | Dpharm Ltd | Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy |
| WO2012069605A1 (en) * | 2010-11-26 | 2012-05-31 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Novel e,e-diene compounds and their use as medicaments and cosmetics |
| MX2019010837A (es) * | 2017-03-14 | 2019-12-19 | Polyactiva Pty Ltd | Conjugado biodegradable de farmaco-polimero. |
| IL303659A (he) | 2020-12-23 | 2023-08-01 | Etherna Immunotherapies Nv | שומנים מייננים |
| WO2022207938A1 (en) * | 2021-04-02 | 2022-10-06 | Universiteit Gent | Ionizable lipids and lipid nanoparticles comprising said ionizable lipids for delivery of therapeutic agents |
-
2023
- 2023-10-20 WO PCT/EP2023/079320 patent/WO2024084056A1/en not_active Ceased
- 2023-10-20 JP JP2025522512A patent/JP2026512620A/ja active Pending
- 2023-10-20 CN CN202380083509.4A patent/CN120303251A/zh active Pending
- 2023-10-20 AU AU2023362573A patent/AU2023362573A1/en active Pending
- 2023-10-20 KR KR1020257016615A patent/KR20250091282A/ko active Pending
- 2023-10-20 IL IL320213A patent/IL320213A/he unknown
- 2023-10-20 EP EP23789331.8A patent/EP4605375A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN120303251A (zh) | 2025-07-11 |
| KR20250091282A (ko) | 2025-06-20 |
| JP2026512620A (ja) | 2026-04-20 |
| WO2024084056A1 (en) | 2024-04-25 |
| EP4605375A1 (en) | 2025-08-27 |
| AU2023362573A1 (en) | 2025-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4199934A4 (en) | FUNCTIONAL IONIZABLE PHOSPHOLIPIDES | |
| SG11202102921WA (en) | Ionizable amine lipids | |
| CA216403S (en) | Hoodie | |
| EP4347577A4 (en) | KC2-TYPE LIPIDS | |
| IL325587A (he) | ליפידים הניתנים ליינון | |
| IL325487A (he) | ליפידים הניתנים ליינון | |
| IL315356A (he) | ליפידים בעלי יכולת ינון וקומפוזיציות המכילות אותם | |
| CA236863S (en) | Vitamin | |
| IL318544A (he) | ליפידים קטיוניים הניתנים ליינון המשלבים סיליקון | |
| CA214906S (en) | Multi-cooker | |
| IL320213A (he) | ליפידים ניתנים ליוניזציה | |
| IL292335B1 (he) | ליפידים של פוליאתילן גליקול | |
| IL320210A (he) | לפידים יוניים חדשים | |
| CA3297138A1 (en) | Ionizable lipids | |
| CA3271221A1 (en) | Ionizable lipids | |
| EP4419148A4 (en) | IONIZABLE CATIONIC COMPOUND | |
| CA3270349A1 (en) | Novel ionizable lipids | |
| HK40103657A (en) | Ionizable lipids for nanomaterials | |
| HK40096029A (en) | Functional ionizable phospholipids | |
| CA220099S (en) | An electrosprayer | |
| CA3286597A1 (en) | Ionizable anionic lipids | |
| HK40104510A (en) | Nanomaterials comprising an ionizable lipid | |
| GB2619010B (en) | An electrical fitting | |
| HK40054140A (en) | Ionizable amine lipids | |
| CA215379S (en) | E-track |